Big Indian state scales down vaccinations, citing shortage
FILE PHOTO: Officials arrange boxes containing vials of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, […]
COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), […] A team of scientists in Israel recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2 (also […] Germany has begun ramping up the use of the coronavirus vaccine made by AstraZeneca, after authorities last week gave the […] Tim Dupin thought — or at least hoped — that Missouri firefighters, paramedics and other emergency medical services personnel would […] BEIJING (Reuters) – China’s production capacity of COVID-19 vaccines could be sufficient for 40% of the population to have been […] New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus […] As managed-care giant Kaiser Permanente assumes a prominent role in California’s new covid-19 vaccination strategy, it is drawing mixed reviews […] (HealthDay)—A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting […] Hackensack Meridian Health CEO on COVID-19 vaccination process Bob Garrett, Hackensack Meridian Health CEO, speaks on vaccination progress in New […]vaccine
Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2
Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response
Germany looks to AstraZeneca shot to boost vaccine rollout
Firefighters — ‘health care providers on a truck’ — signal pandemic burnout
China's COVID-19 vaccine production capacity may cover 40% of population by mid-2021: disease control head
New COVID-19 variants can evade antibodies that work against original form of the virus
Kaiser Permanente, Big Player in California Vaccine Effort, Has Had Trouble Vaccinating Own Members
AstraZeneca COVID-19 vaccine easy to update in response to variants
Novavax COVID-19 vaccine could see approval by May, CEO says